Pranlukast
Specifications
103177-37-3CAS Number
808-178-9EC Number
N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamideIUPAC Name
C27H23N5O4Chemical Formula
481.5 g/molMolecular Weight
Pranlukast; 103177-37-3; Ono-1078; Azlaire; ONO 1078; Ono-RS-411; N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide; SB 205312; CCN 00401; RS 411; ONO-RS 411; DTXSID3043782; RS-411; CCN-00401; TB8Z891092; SB-205312; DTXCID1023782; N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide; pranlukastum; N-(4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl)-4-(4-phenylbutoxy)benzamide; RefChem:175724; R03DC02; 8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran; N-(4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide; 808-178-9; N-(4-OXO-2-(1H-TETRAZOL-5-YL)-4H-CHROMEN-8-YL)-4-(4-PHENYLBUTOXY)BENZAMIDE; Pranlukast (INN); Onon; C27H23N5O4; 4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran; CHEMBL21333; MFCD00864631; n-[4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide; NCGC00181765-01; PRANLUKAST [INN]; 4-oxo-8-[4-(4-phenylbutoxy)benzoylamino]-2-(tetrazol-5-yl)-4h-1-benzopyran; N-{4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide; 8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran; N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide;N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide; Azlaire (TN); Pranlukast [INN:BAN]; SR-05000001474; UNII-TB8Z891092; Pranlukast (Standard); PRANLUKAST [MI]; PRANLUKAST [MART.]; SCHEMBL3693; PRANLUKAST [WHO-DD]; MLS006010078; GTPL3634; ONO RS-411; orb1227110; orb1310378; SCHEMBL18058592; SCHEMBL29349894; SCHEMBL31756724; CHEBI:94810; HY-B0290R; GLXC-21321; HMS2089H16; HMS3650A14; HMS3714E03; HY-B0290; Tox21_112952; AC-696; BDBM50023198; MFCD24539454; AKOS015967342; CCG-220661; DB01411; FP27120; SB19080; N-(4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide; AS-15105; DA-77034; SMR004701229; SY113837; CAS-103177-37-3; NS00068609; P2115; C71133; D08408; AB01275471-01; F869021; L013134; Q7238392; SR-05000001474-1; SR-05000001474-2; SR-05000001474-3; BRD-K97045029-001-01-9; BRD-K97045029-001-02-7; BRD-K97045029-001-04-3; 8-[4-(4-phenylbutyloxy)benzoyl]amino-2-(tetrazol-5-yl)-4-oxo-4H-1-benzopyran; Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-; N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide; N-[4-oxo-2-(2H-tetrazol-5-yl)-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide; BENZAMIDE, N-(4-OXO-2-(2H-TETRAZOL-5-YL)-4H-1-BENZOPYRAN-8-YL)-4-(4-PHENYLBUTOXY)-; KNT; N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide (ONO-RS-411); N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide(ONO-RS-411)Synonyms
